Document is current
Any future updates will be listed below
-
Authors
Wei, Shu
Freeman, Daniel
Harris, Victoria
Rovira, Aitor
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR202385)
- License Information
-
More Information
Article History
Received: 25 March 2024
Accepted: 12 July 2024
First Online: 24 July 2024
Competing interests
: Daniel Freeman is the scientific founder of Oxford VR, a University of Oxford spin-out company, which commercialises automated VR therapies. The other authors do not have any competing interests.
